SK3 Group Acquires Xenotis For $40 Million

Bookmark and Share

(RTTNews) - Thursday, SK3 Group Inc.'s (SKTO.PK: News ) new parent company Healthcare of Today Inc. acquired Xenotis Pty Ltd., the Australian-based producer of advanced human tissue engineering technology for $40 million. Xenotis is known for its custom-designed biosynthetic graft, produced according to strict specifications for use in peripheral bypass or arteriovenous access.

Back to news